Unusual Action Warns That Institutions Are Reducing Exposure
There was an odd brew of strength and weakness on Monday.
There was an odd brew of strength and weakness on Monday.
I’m buying two promising biotech names as the market grows more nervous.
The “quick” return to “normal” is a myth. Even if there’s resolution soon, the damage will impact affordability.
I’m enjoying the aggressive speculative trading, but growing worried about some upcoming catalysts and toppy technical action.
Investors must stay vigilant with these macro headwinds coming in.
The market got nothing new on Iran except a harder line from President Trump.
Small stocks are now leading and investors are finding plenty of names that are not wildly overbought.
The Chinese stock watchdog is increasingly applying the country’s securities law overseas.
The SpaceX, Anthropic, and OpenAI IPOs could create market volatility.
Money rotated into smaller stocks and drove a breakout for the S&P 500 Equal Weight Index.